<div id="readability-page-1">04:06 PM EST, 12/26/2025 (MT Newswires) -- Health care stocks were edging up late Friday afternoon with the NYSE Health Care Index and the State Street Health Care Select Sector SPDR ETF (XLV) each fractionally higher.The iShares Biotechnology ETF (IBB) fell 0.7%.In corporate news, Eli Lilly ( LLY ) will pay a $40 million upfront payment and a $15 million equity investment to ABL Bio, the latter said Friday. The upfront payment is for the license, research, and collaboration agreement for ABL's Grabody platform, ABL said, adding that the two parties are carrying out joint research and development on multiple therapeutic candidates. Eli Lilly ( LLY ) shares rose 0.1%.Johnson &amp; Johnson ( JNJ ) shares were fractionally lower after the company said Friday that a phase 2b trial assessing JNJ-95475939 in moderate to severe atopic dermatitis was terminated early after interim analysis showed that it did not meet the target efficacy.Can-Fite BioPharma ( CANF ) shares jumped 22% after receiving a patent from the Brazilian Patent Office for its A3 adenosine receptor, or A3AR, drugs to treat sexual dysfunction.Aptevo Therapeutics ( APVO ) shares fell 35% after the company said it will implement a 1-for-18 reverse stock split, effective at the start of trading on Tuesday. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

CANF

礼来

医疗保健股票在周五下午小幅上涨。礼来将向 ABL Bio 支付 4000 万美元的预付款和 1500 万美元的股权，以达成合作协议。强生的特应性皮炎 2b 期临床试验提前终止。Can-Fite BioPharma 的股票在巴西获得专利后上涨了 22%。Aptevo Therapeutics 的股票因进行 1 拆 18 的反向股票拆分而下跌了 35%

板块更新：医疗保健类股在午后小幅上涨